Yaroslav D Shansky, Oleg O Yanushevich, Alina V Gospodarik, Igor V Maev, Natella I Krikheli, Oleg V Levchenko, Andrew V Zaborovsky, Vladimir V Evdokimov, Alexander A Solodov, Petr A Bely, Dmitry N Andreev, Anna N Serkina, Sulejman S Esiev, Anastacia V Komarova, Philip S Sokolov, Aleksei K Fomenko, Mikhail K Devkota, Sergei V Tsaregorodtsev, Julia A Bespyatykh
INTRODUCTION: The new coronavirus disease, COVID-19, poses complex challenges exacerbated by several factors, with respiratory tissue lesions being notably significant among them. Consequently, there is a pressing need to identify informative biological markers that can indicate the severity of the disease. Several studies have highlighted the involvement of proteins such as APOA1, XPNPEP2, ORP150, CUBN, HCII, and CREB3L3 in these respiratory tissue lesions. However, there is a lack of information regarding antibodies to these proteins in the human body, which could potentially serve as valuable diagnostic markers for COVID-19...
2024: Frontiers in Medicine